This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

IgG4-related disease (IgG4 - RD) and autoimmune pancreatitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Immunoglobulin G4 (IgG4)-related systemic disease (IgG4-RSD) is a systemic entity associated with autoimmune pancreatitis (AIP)

  • AIP is a distinct type of chronic pancreatitis and is characterized by abundant infiltration of Immunoglobulin G4 (IgG4)-positive plasma cells and associated fibrosis that lead to organ dysfunction
    • there are three recognized patterns of AIP
      • diffuse, focal, and multifocal
    • patients with AIP typically present with jaundice or abdominal discomfort, severe abdominal pain, or acute pancreatitis

  • other organ involvements take the form of sclerosing cholangitis, sclerosing cholecystitis, sclerosing sialadenitis, retroperitoneal fibrosis, and interstitial nephritis

  • lung diseases related to IgG4 have been described to occur with or without other organ involvement
    • these diseases include interstitial lung disease (ILD), pulmonary inflammatory pseudotumor, and lymphomatoid granulomatosis

Notes (3):

  • autoimmune pancreatitis can present as acute or chronic pancreatitis
    • most common clinical presentation is painless jaundice
    • more commonly occurs in patients over age 60 with a three to one male predominance
    • serologic marker for autoimmune pancreatitis is an increased concentration of circulating IgG4
    • most often responsive to steroid treatment or alternatively to other immune modulators in steroid resistant cases

Reference:

  • Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-51.
  • Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57-66.
  • Hines O J, Pandol S J. Management of chronic pancreatitis BMJ 2024; 384 :e070920 doi:10.1136/bmj-2023-070920

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.